Conavi Medical Corp. (TSXV:CNVI)
Canada flag Canada · Delayed Price · Currency is CAD
0.1800
-0.0100 (-5.26%)
Aug 20, 2026, 3:56 PM EST

Conavi Medical Financials Overview

Millions CAD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
0.789.122.162.362.7
Revenue Growth
-91.87%322.12%-8.59%-12.44%-
Gross Profit
0.747.630.051.41.69
Operating Income
-19.44-14.85-26.23-21.63-10.28
Net Income
-17.85-20.52-43.62-26.09-11.87
Earnings Per Share
-0.22-0.36-7.08-4.24-1.93
EPS Growth
-----

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
North America (Excluding Canada)
-0.010.080.050.08
Asia
0.779.122.072.292.58
Canada
--00.030.04
Total
0.789.122.162.362.7

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash & Investments
4.495.840.4414.174.59
Total Debt
18.2219.9183.1854.4131.88
Net Cash (Debt)
-13.72-14.07-82.74-40.24-27.29
Net Cash Growth
-----
Net Cash Per Share
-0.17-0.24-13.43-6.54-4.43

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
-23.68-25.1-20.15-19.98-8.85
Capital Expenditures
-0.05-0.07-0.58-0.69-0.93
Free Cash Flow
-23.74-25.17-20.72-20.66-9.78
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
95.63%83.61%2.45%59.22%62.67%
Operating Margin
-2498.20%-162.81%-1213.93%-914.76%-380.89%
Pretax Margin
-2294.22%-224.91%-2018.28%-1103.51%-439.52%
Profit Margin
-2294.22%-224.91%-2018.28%-1103.51%-439.52%
FCF Margin
-3050.90%-275.96%-958.95%-874.07%-362.22%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
31.935.64---